20192022年成都市简阳市人类免疫缺陷病毒筛查阳性样本补充试验结果分析

Analysis of the supplementary test results of HIV screening positive samples in Jianyang City, Chengdu from 2019 to 2022

  • 摘要:
    目的 分析2019—2022年成都市简阳市人类免疫缺陷病毒(HIV)筛查阳性样本补充试验结果,评价不同HIV检测方法,为该地区HIV检测策略的制定提供依据。
    方法 按国家技术规范对2019—2022年HIV确证实验室1 172份筛查阳性样本进行免疫印迹法(WB)补充试验,采用快速检测试验、酶联免疫吸附试验(ELISA)和化学发光试验(CLIA)进行检测,收集上述3种试验检测结果并建立数据库进行统计学分析。
    结果 1 172份送检样本经补充试验检测,阳性样本1 022份(87.20%),不确定75份(6.40%),阴性75份(6.40%)。3种不同HIV筛查方法的阳性结果与补充试验一致。快速检测试验筛查出的样本补充试验阳性率最高(88.54%),ELISA次之(86.98%),CLIA最低(85.92%),差异有统计学意义(χ2=9.505,P<0.05)。阳性样本WB带型以gp160和gp120检出率最高,均为100.00%,p55和p17最低,分别为50.68%和63.41%;不确定样本WB带型主要为gp120(81.33%)和p24(46.67%),39例不确定样本随访检测后,转阳29例,随访转阳率高达74.36%。
    结论 对于CLIA筛查阳性WB补充试验结果阴性的样本和WB补充试验结果为不确定的样本,应直接加做HIV核酸检测,避免漏检造成HIV感染扩散。

     

    Abstract:
    Objective To analyze the supplementary test results of HIV screening positive samples in Jianyang City, Chengdu from 2019 to 2022, to evaluate different HIV testing methods, and to provide a basis for the development of HIV testing strategies in the local area.
    Methods Western blotting (WB) supplementary test was conducted on 1 172 screening positive samples from the HIV confirmatory laboratory in 2019‒2022 according to the national technical specifications. The samples were tested by the rapid test, enzyme-linked immunoassay (ELISA), and chemiluminescence immunoassay (CLIA). The test results of the three HIV screening methods were collected and a database was established for statistical analysis.
    Results A total of 1 172 samples were tested through supplementary test, of which 1 022 samples were tested positive (87.20%), 75 were uncertain (6.40%), and 75 were negative (6.40%). The positive results of the three different HIV screening methods were consistent with the supplementary test. The rapid test had the highest positively supplementary rate of 88.54%, followed by ELISA of 86.98%, and CLIA of 85.92%. The difference was statistically significant (χ2=9.505, P<0.05). The detection rate of WB band patterns in positive samples were the highest at 100.00% for gp160 and gp120, and lowest at 50.68% and 63.41% for p55 and p17, respectively. The WB band patterns of uncertain samples were mainly gp120 (81.33%) and p24 (46.67%). Among the 75 uncertain samples, 39 were followed up and 29 of which turned positive, with a high positive conversion rate of 74.36%.
    Conclusion It is necessary to directly add HIV nucleic acid testing to samples with positive WB supplementary test results and samples with uncertain WB supplementary test results in combination with CLIA, so as to avoid the spread of HIV infection caused by missed detections.

     

/

返回文章
返回